EUVIMEDEUVIMED entdecken
Fallbericht

Resolution of portal hypertension in a patient with cystic fibrosis after treatment with CFTR modulator: A case report

Erica Loon, Joanne Billings, Nicholas Lim

Journal of Cystic Fibrosis · 2025

DOI: 10.1016/j.jcf.2025.03.668 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Erica Loon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Hypertension, Portal, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit nennt 6 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Portal hypertension (pH) secondary to cystic fibrosis liver disease (CFLD) is the fourth most common cause for mortality (after respiratory/cardiorespiratory, transplant-related, and cancer-related) in adults with cystic fibrosis (CF) and more often occurs in the absence of cirrhosis (i.e. non-cirrhotic pH, NCPH). Here, we describe a patient with NCPH secondary to CFLD, with resolution of pH after starting a cystic fibrosis transmembrane conductance regulator (CFTR) modulator. As demonstrated in this patient, CFTR modulators may provide extra-pulmonary benefits including reversal of NCPH. Long-term use of CFTR modulators could potentially result in reductions in mortality from pH and need for future liver or combined lung-liver transplantation in patients with CFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisHypertension, PortalCystic Fibrosis Transmembrane Conductance RegulatorHumansAdultMaleFemaleChloride Channel AgonistsTreatment Outcome

Stichwörter der Autor:innen

Cystic fibrosis liver diseaseCystic fibrosis transmembrane conductance regulator modulatorsNon-cirrhotic portal hypertensionPortal hypertensionPorto-sinusoidal vascular disease

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorChloride Channel Agonists

Autor:innen und Institutionen

  • Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN, USA. Electronic address: Nicholas_Lim@urmc.rochester.edu.

Zitieren

APA

Loon, E., Billings, J., & Lim, N. (2025). Resolution of portal hypertension in a patient with cystic fibrosis after treatment with CFTR modulator: A case report. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.03.668

Vancouver

Loon E, Billings J, Lim N. Resolution of portal hypertension in a patient with cystic fibrosis after treatment with CFTR modulator: A case report. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.03.668

BibTeX
@article{Loon2025,
  author = {Loon, Erica and Billings, Joanne and Lim, Nicholas},
  title = {Resolution of portal hypertension in a patient with cystic fibrosis after treatment with CFTR modulator: A case report},
  journal = {Journal of Cystic Fibrosis},
  year = {2025},
  doi = {10.1016/j.jcf.2025.03.668}
}
Kostenlos starten →